Any interest in a remote Inkhaven?
EDIT: express interest here
I love the idea of Inkhaven but don't have the cash (and am not super interested in becoming a fancy writer/researcher, but would like to write better). What about an online version - would also run during the month of November so could cadge some of the Inkhaven tailwind, but would be free and online-only.
You'd have a community of likeminded people all trying to do the same thing. We could set up a tontine; everyone chips in $50 or something and then if you've posted one thing a day for the full month you split the pool at the end.
Yep, we considered this! My guess is we won't have the team capacity to run this during actual Inkhaven, but I would love to see someone else make it happen.
Do you have thoughts on naming/branding? Happy to find my own name but if you'd prefer I can also label at as a sort of remote Inkhaven type of thing.
We had the idea to make it the non-fiction blogging version of NaNoWriMo, called NaBloWriMo. I still think that’d be a cool internet-wide institution.
(I’m pro it happening, but I want to keep the Inkhaven branding separate, to refer to Lighthaven’s residency.)
Speaking from recent experience, yet it is. I tried it this month, missed a day, tapped out at the annoyingly close 27 posts (with the aforementioned day's lag). If you work a full 9-5 or have other extracurricular responsibilities, writing more than 1 vomit draft a day will be very difficult.
Could LLM psychiatrists be better than meat ones?
[Not medical advice, obviously]
I had a call with my psychiatrist – the first one in about a year; I hadn’t really felt the need to see him until then – and we spoke for a scant ten minutes. I gave a one-minute description of how I was feeling, and he fiddled with the dose of a mood stabiliser I take and that was it.
No attempt to dig deeper into how I was feeling, or give me a standard questionnaire like the PHQ-9 or MADRS which would have given a numerical idea of how I was doing over time. The session cost £150 for ten minutes.
I wondered if an LLM couldn’t do a better job than this guy.
So I went and downloaded a copy of the Maudsley and shoved it into a Claude project. (It’s over 900 pages, so I trimmed the PDF to just the ~150 pages on depression first.) I gave it custom instructions to ensure it always checked and referenced the Maudsley guidelines.
Here is it dismantling some common myths (Opus 4.5):
User: how long does it take antidepressants to start working in depression?
The Maudsley is clear on this, and it’s actually good news: the idea that antidepressants take 2–4 weeks to work is a myth.
All antidepressants show a response pattern where the rate of improvement is highest during weeks 1–2 and lowest during weeks 4–6. Statistical separation from placebo is seen at 2–4 weeks in single trials (which is where the “lag effect” idea comes from), but after only 1–2 weeks in meta-analyses. When large numbers of patients are treated and detailed rating scales are used, an antidepressant effect is statistically evident at 1 week.
In clinical practice using simpler observations, an antidepressant effect in an individual is usually seen by 2 weeks.
The practical implication: in those who will ultimately respond, virtually all will have begun to show at least minor improvement by 4 weeks. Those showing no discernible improvement at this point will very probably never respond to that drug at that dose. …
User: what’s the evidence for pushing escitalopram to doses higher than 20mg? search online as well.
The Maudsley says there’s minimal evidence for SSRI dose escalation in general, but specifically notes that escitalopram (along with venlafaxine and tricyclics) may be an exception.
The Furukawa 2019 meta-analysis found SSRIs plateau around 20–40mg fluoxetine equivalents (~10–20mg escitalopram). But a Bayesian reanalysis suggested escitalopram specifically can be escalated higher than other SSRIs—up to ~30mg for ages 30–65.
A Korean RCT (2019) found 30mg vs 20mg in non-remitters showed improved depressive symptoms on MADRS, but not increased response/remission rates—a modest continuous effect, not a categorical one.
An open-label pilot escalating to 50mg found median remission dose was 30mg, with 38% of remitters needing 50mg. Tolerability declined above 40mg.
Why escitalopram might be different: It has a unique allosteric mechanism—binding to an allosteric site decreases its own dissociation rate from SERT, potentially potentiating effect at higher doses. Other SSRIs don’t do this.
Safety: QTc increases ~10.7ms at 30mg—modest and generally not clinically concerning.
Bottom line: 30mg is reasonable and better-supported than high doses of other SSRIs, though the evidence isn’t definitive.
Certainly it seems like, if not a replacement for a traditional psychiatrist, an LLM + a copy of the Maudsley is very good foil for classical care.
People seemed keen in taking part in a remote Inkhaven. I'll put together a loose community and run a tontine - to be split between those who post every day of November. Express interest here.